KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

By: Business Wire

May 22, 2025 at 21:01 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.

Contacts

Media Contact

Naomi Goumillout

Agilent Technologies

+1.978.314.1862

naomi.goumillout@agilent.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

3 European Stocks to Carry Investors Through the Back Half of 2026 ↗

Today 11:05 EDT

Via MarketBeat

Meta’s WhatsApp Shakeup Could Put India at the Center of Its Next Growth Push ↗

Today 10:30 EDT

Via MarketBeat

Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the Move ↗

Today 10:30 EDT

Via MarketBeat

3 Big Banks Plan Double Digit Dividend Increases After Passing Fed Stress Test ↗

Today 9:55 EDT

Via MarketBeat

3 ETFs Offering Exposure to Latin America’s Stock Market Rally ↗

Today 9:20 EDT

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	242.87	+4.53 (1.90%)
AAPL	296.34	+6.98 (2.41%)
AMD	552.30	-28.61 (-4.93%)
BAC	58.02	+1.04 (1.82%)
GOOG	358.47	+5.14 (1.45%)
META	624.14	+60.85 (10.80%)
MSFT	386.76	+13.74 (3.68%)
NVDA	196.62	-3.47 (-1.74%)
ORCL	145.79	-0.76 (-0.52%)
TSLA	431.99	+11.39 (2.71%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Contacts

More News

Recent Quotes

Starting at $3.75/week.

Subscribe Today